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RetrovirusesBryan R. Cullen1
All retroviral virions contain two copies of their RNAHoward Hughes Medical Institute and Department
genome complexed with the nucleocapsid protein andof Genetics
reverse transcriptase (RT). This ribonucleoprotein com-Duke University Medical Center
plex is located within a shell formed by the capsid pro-Durham, North Carolina 27710
tein that also encloses the viral integrase (IN). An addi-
tional protein, termed VPR, is packaged within the
capsid of HIV-1. All retroviral capsids are surroundedThe mechanisms used by pathogenic human viruses to
by a lipid membrane through which protrude the viralcross the plasma membrane have been the focus of
envelope (ENV) glycoproteins. A final viral structural pro-considerable attention. However, penetration into the
tein, termed matrix (MA), is found in a layer betweencell cytoplasm is insufficient to permit the replication of
capsid and membrane and, in HIV-1, may also be pres-many virus species. Specifically, all DNA viruses, except
ent in small amounts within the capsid.for pox viruses, as well as some viral families that bear
Research into the early steps of retroviral infectionRNA genomes, including retroviruses and influenza vi-
has primarily focused on HIV-1 and on murine leukemiaruses, replicate in the nucleus. Only here can these vi-
virus (MLV), a prototypic oncogenic retrovirus. In theruses gain access to the cellular factors they require for
case of HIV-1, infection initiates with binding of ENV tothe amplification and transcription of their genome and
the CD4 receptor, followed by recruitment of a corecep-for the posttranscriptional processing of viral mRNA
tor such as CCR5 (Figure 1A). These interactions causespecies. Therefore, these viruses not only have to cross
conformational shifts in ENV that induce fusion of thethe plasma membrane but must also traverse the cyto-
virion and target cell membranes and entry of the viral
plasm and then enter the cell nucleus. In this review, I
capsid into the cytoplasm (Figure 1B). At this stage, the
will briefly outline what is known about this process,
HIV-1 capsid undergoes partial disassembly and also
using Human Immunodeficiency Virus Type 1 (HIV-1)
commences reverse transcription of the RNA genome,
and Adenovirus Type 2 (Ad2) as primary examples. A
leading to the generation of a subviral particle termed
more comprehensive discussion is provided in a recent
a preintegration complex, or PIC (Figure 1C). The PIC
review by Whittaker et al. (2000). contains the double-stranded linear DNA intermediate
Introduction to Nuclear Import as well as at least four viral proteins, i.e., MA, RT, IN, and
Considerable progress has recently been made in un- VPR, and has been reported to be 56 nm in average
derstanding the mechanisms underlying the sequence- diameter (Miller et al., 1997).
specific transport of macromolecules between nucleus Although the steps involved in HIV-1 PIC formation
and cytoplasm and the critical role played by the nuclear remain largely undefined, the cellular protein cyclophilin
pore complex (NPC) in this process (Reviewed by Na- A appears to play a critical role in the appropriate disas-
kielny and Dreyfuss, 1999). NPCs are large (125 MDa) sembly of the HIV-1 capsid early after infection (Braaten
structures that span the nuclear membrane and pro- et al., 1996). While cyclophilin A function is therefore
trude into both cytoplasm and nucleoplasm. All nucleo- essential for HIV-1 infection in culture, this host cell
cytoplasmic transport occurs via the central aqueous activity is not required for the replication of other retrovi-
channel found in NPCs. Importantly, the maximum diam- ral species, including other lentiviruses.
eter of this channel may be only 25 nm. As many Retroviral replication requires integration of the provi-
viral nucleocapsids are considerably larger than 25 nm, ral DNA intermediate into the host cell genome, where
achieving the nuclear import of the viral genome pre- it is expressed under the control of host cell transcription
sents a potentially formidable challenge. factors. However, PICs derived from many retroviruses,
Most active nuclear import is mediated by nuclear including MLV, are unable to enter intact nuclei. Instead,
transport receptors belonging to a family of proteins the MLV genome undergoes cytoplasmic reverse tran-
termed importins or karyopherins. While each importin scription and the MLV PIC then waits for the breakdown
family member is able to recognize one or more distinct in the nuclear envelope that occurs during mitosis to
classes of nuclear localization signal (NLS) directly, one enter the nucleus. As a result, MLV is unable to replicate
commonly utilized import receptor, termed importin  in nondividing cells. In contrast, HIV-1 is able to produc-
(Imp ), also utilizes the importin  (Imp ) family of tively infect nondividing cells (Weinberg et al., 1991) and
adaptor proteins for cargo recruitment. For example, the HIV-1 PIC must therefore be able to enter intact
many basic NLSs are recognized by Imp , leading to nuclei. The primary protein mediator of this nuclear im-
the cytoplasmic formation of a ternary complex con- port is the HIV-1 IN protein, which has been shown to
contain a short NLS sequence that is important for PICsisting of Imp , Imp , and the NLS-bearing cargo. This
import into the nucleus, but dispensable for the enzy-complex then docks at the cytoplasmic face of the NPC,
matic activity of IN (Figure 1D) (Bouyac-Bertoia et al.,due to specific interactions between Imp  and compo-
2001). While the cellular target for the unusual IN NLSnents of the NPC, before migrating through the NPC into
sequence is not presently known, this NLS appears dis-the nuclear interior, where the complex is disassembled.
tinct from the class of basic NLSs recognized by Imp .
A second component of the HIV-1 PIC that is impor-
tant for nuclear entry is not a protein but rather an un-1 Correspondence: culle002@mc.duke.edu
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Figure 1. Viral Invasion of the Infected Cell Nucleus
Schematic representation of key steps in the nuclear entry of the HIV-1 preintegration complex (A–D) and of the Ad2 genome (I–V). See text
for detailed discussion.
usual DNA structure (Zennou et al., 2000). Specifically, reports have argued that this basic sequence within MA
is dispensable for infection of nondividing cells (Reil etthe HIV-1 DNA intermediate contains a discrete, cen-
trally located region where a third DNA strand forms a al., 1998). A second protein that may selectively promote
the infection of nondividing cells is the small HIV-1 auxil-short overlap termed the central DNA flap (Figure 1C).
This central DNA flap, which is formed during reverse iary protein VPR (Vodicka et al., 1998). VPR has been
reported to associate with NPCs and to interact withtranscription, may enhance the nuclear entry of the PIC
by recruiting karyophilic cellular proteins that directly NPC components. Further, VPR is present in the PIC
and HIV-1 mutants lacking VPR replicate less effectivelymediate PIC nuclear import. Alternately, the central DNA
flap may be required for the PIC to achieve a conforma- than wild-type HIV-1 in nondividing macrophages. How-
ever, it is not clear that this defect is due to poor PICtion appropriate for import. As noted above, the PIC has
been proposed to be 56 nm in diameter, yet is known nuclear import, as others have presented data showing
that VPR-deficient HIV-1 can infect nondividing cellsto contain an 9.4 kb DNA intermediate that is up to
3.3 m in length. Clearly, this DNA molecule must be efficiently (Reil et al., 1998; Bouyac-Bertoia et al., 2001).
Therefore, although VPR may well facilitate the infectioncondensed within the PIC, and it is in fact known that
IN forms a multimer that juxtaposes the two ends of of nondividing cells by HIV-1, it does not play an essen-
tial role in the nuclear import of the HIV-1 PIC.the linear proviral intermediate (Figure 1C) (Miller et al.,
1997). The central DNA flap may allow the condensation Adenoviruses
Ad2 virions are 90 nm in diameter and form nonenvel-of this DNA molecule into the PIC in a form that is permis-
sive for nuclear translocation. Given the large size of oped icosahedrons with twelve vertices and twenty fac-
ets. The facets consist largely of trimers of the hexonthe PIC, and the small diameter of the central channel
of the NPC, it seems likely that the PIC must undergo protein while the vertices are capped by fibers that are
anchored to the virion by the penton base protein. Withinsignificant conformational shifts and/or deformations
during nuclear import. the capsid is the linear DNA genome, which is associ-
ated with several virion proteins. These include proteinIt appeared possible that HIV-1 might utilize the same
mechanism as MLV to infect dividing cells and use the VI, which anchors the DNA to the inner wall of the capsid;
protein VII, which is important for condensation of theNPC entry route solely to infect nondividing cells. How-
ever, mutation of the NLS present in IN or deletion of genome; and the terminal protein, which is bound to the
ends of the genome.the central DNA flap inhibits HIV-1 infection of both non-
dividing and dividing cells (Zennou et al., 2000; Bouyac- Infection of cells by Ad2 initiates with binding of the
fiber protein to the coxsackie adenovirus receptorBertoia et al., 2001). These data suggest that the active
nuclear import of the PIC is a key step in HIV-1 infection (CAR), followed by binding of the penton base protein
to a coreceptor belonging to the V integrin family (Fig-of all target cells and also imply that the nuclear entry
of the MLV PIC during mitosis may not be a passive ure 1, I). This latter interaction induces release of the
fiber protein and initiates internalization of bound virionsprocess.
Two other HIV-1 proteins have been proposed to play into early endosomes via clathrin coated pits (Figure 1,
II). Here, the drop in pH induces an at-present poorlya specific role in the infection of nondividing cells. The
first of these is the MA protein, which is present in the defined conformational shift in the Ad2 virion that in-
duces the rupture of the early endosome membrane andPIC and which has been proposed to contain a basic
NLS that targets the PIC for nuclear import (Bukrinsky allows the entry of the partially uncoated virion into the
cytoplasm (Figure 1, III) (Greber et al., 1993). This ruptureet al., 1993). However, other groups have been unable
to demonstrate a functional NLS within MA and several appears to be mediated, at least in part, by the integrin/
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penton base protein complex. Once the virion reaches time after infection and can be readily detected by elec-
tron microscopy.the reducing environment of the cytoplasm, the integrin/
penton base complex also induces the activation of an Influenza Viruses
The negative-sense RNA genome of influenza virus ex-Ad2-encoded cysteine protease, termed L3/p23, lo-
cated within the virion. This activation induces further ists in eight distinct segments. In influenza virions, each
of these genomic segments is coated by the viral nucleo-disassembly of the Ad2 virion, including degradation of
protein VI that anchors the Ad2 DNA genome within the protein (NP) and these are in turn located within an inner
shell consisting of the viral matrix protein M1. The outercapsid (Greber et al., 1996) (Figure 1, IV). The subsequent
directional movement of the partially uncoated Ad2 vi- viral envelope contains the M2 integral membrane pro-
tein as well as the viral hemagglutinin (HA) protein. Afterrion through the cytoplasm to the nucleus is thought to
be mediated by the interaction of virion particles with initial binding to target cells, mediated by the HA glyco-
protein, virions are internalized via endocytosis. Oncethe microtubule-dependent dynein molecular motor
complex. the influenza virions reach late endosomes, they en-
counter a pH sufficiently low to induce a conformationalOnce the partially disassembled Ad2 virion reaches
the nuclear periphery, it docks at the NPC in a process shift in HA that induces membrane fusion.
Low pH also induces a conformational shift in the M1that is likely mediated by NLS sequences present on
the hexons. This docking event is blocked by inhibitors protein that induces the essentially complete disassem-
bly of the influenza virion and precipitates the releasespecific for Imp, and therefore probably involves re-
cruitment of Imp/Imp heterodimers to the virion (Fig- of the eight viral ribonucleoprotein complexes into the
cell cytoplasm (Bui et al., 1996). This latter step requiresure 1, IV) (Saphire et al., 2000). Docking at the NPC
induces the final disassembly of the Ad2 virion and acti- the action of the M2 ion channel, which promotes acidifi-
cation of the virion interior. Once the eight viral ribo-vates the translocation of the linear DNA genome into
the cell nucleus (Figure 1, V) (Greber et al., 1997). The nucleoproteins reach the cytoplasm, they are able to
enter the nucleus individually as the result of Imp-genome is thought to be imported as a complex with a
small subset of virion proteins that includes the terminal specific NLS sequences present on the viral NP (O’Neill
et al., 1995).protein and DNA binding protein VII. While the terminal
protein contains an NLS, it remains unclear whether this Perspective
This brief overview of the strategies used by viruses toplays a role in Ad2 genomic DNA import.
Herpes Viruses transport their genomes into the nuclei of target cells
reveals that there are considerable differences in detail.Herpes Simplex Virus Type 1 (HSV-1) is a large DNA
virus bearing an icosahedral capsid of125 nm in diam- Nevertheless, several common themes are apparent.
Thus, the nuclear import of viral nucleic acids appearseter. This capsid is covered first by a layer of proteins,
termed the tegument, and finally by an envelope through to be generally mediated by associated viral proteins
that contain NLS sequences that are, in turn, recognizedwhich protrude several viral glycoproteins. HSV-1, like
HIV-1, enters the cell by glycoprotein-mediated fusion by cellular nuclear import factors. Also, nuclear import
of viral genomes invariably occurs via the NPC, with theat the cell surface. This results in the transfer of the
HSV-1 capsid and tegument proteins into the cytoplasm, exception of certain retroviruses, which simply wait for
mitosis to enter the nucleus. Most importantly, viral in-where a subset of the latter dissociate. HSV-1 frequently
infects neurons and the directional movement of the fection generally requires the controlled, step-wise dis-
assembly of virions. This is particularly apparent for viri-HSV-1 capsid toward the nucleus may be particularly
important in these elongated cells. In fact, evidence ons that contain large genomes. For example, the
disassembly of Ad2 virions clearly involves a series ofsuggests that HSV-1, like Ad2, is transported to the
nucleus along microtubules by the dynein molecular carefully choreographed steps beginning shortly after
binding to the cell surface and ending with final dissolu-motor complex (Sodeik et al., 1997).
Once the HSV-1 capsid reaches the nucleus, it docks tion of the Ad2 capsid at the NPC (Greber et al., 1993).
Nuclear import of the HSV-1 genome is in many respectsat an NPC in a process mediated by Imp alone, rather
than by the Imp/Imp heterodimer used by Ad2 (Ojala similar to Ad2, although the HSV-1 capsid is not entirely
disassembled after docking at the NPC. HIV-1 virionset al., 2000). This docking event requires tegument pro-
teins that remain associated with the capsid after cyto- undergo extensive disassembly in the cytoplasm, in a
process that remains only poorly understood, to gener-plasmic entry. After binding at the NPC, the HSV-1 cap-
sid undergoes a conformational shift that results in the ate a PIC that may be only just small enough to move
through the NPC. Finally, influenza virions undergo com-extrusion of the large DNA genome of HSV-1 from the
capsid and into the nucleus through the NPC. An inter- plete disassembly at the time of cytoplasmic entry and
disgorge eight viral ribonucleoproteins that indepen-esting temperature sensitive mutant of HSV-1 allows
capsid docking at the NPC but not DNA entry. This dently enter the nucleus after recruitment of cellular
import factors.mutation has been mapped to a gene encoding a minor
component of the HSV-1 tegument that is associated While considerable progress has been made in the
last decade in deciphering key steps in the processwith capsid pentons. This observation is consistent with
the hypothesis that the pentons provide the channel of viral nuclear entry, much remains to be discovered.
Progress in this area has clearly been slowed by thethrough which the HSV-1 genome is released into the
nucleus after NPC docking (Zhou et al., 1999). Of note, technical difficulties of working with partially disassem-
bled virions, as these are generally far more labile thanthe HSV-1 capsid is unlike the Ad2 capsid in that it does
not disassemble during DNA release. Rather, empty intact virion particles. In addition, for viruses such as
HIV-1, the high total particle to infectious particle ratioHSV-1 capsids remain associated with the NPC for some
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Weinberg, J.B., Matthews, T.J., Cullen, B.R., and Malim, M.H. (1991).makes it difficult to be sure that total HIV-1 PICs isolated
J. Exp. Med. 174, 1477–1482.from the cytoplasm of infected cells are in fact truly
Whittaker, G.R., Kann, M., and Helenius, A. (2000). Annu. Rev. Cellrepresentative of infectious PICs. This concern is in-
Dev. Biol. 16, 627–651.creasingly being addressed by the development of in
Zennou, V., Petit, C., Guetard, D., Nerhbass, U., Montagnier, L., andvitro assays that can accurately recreate the nuclear
Charneau, P. (2000). Cell 101, 173–185.
import of viral genomes and that can therefore be used
Zhou, Z.H., Chen, D.H., Jakana, J., Rixon, F.J., and Chiu, W. (1999).to not only confirm the biological activity of isolated
J. Virol. 73, 3210–3218.
subviral particles but also identify viral and cellular fac-
tors that play a critical role in the import process (Saphire
et al., 2000; Ojala et al., 2000).
Regardless of how each virus achieves virion disas-
sembly and nuclear import, it appears clear that drugs
that could stabilize the virion structure, and hence inter-
fere with nuclear entry of the viral genome, would poten-
tially be effective inhibitors of viral replication. In fact,
a family of antiviral agents that selectively interfere with
the disassembly of influenza virions, by inhibiting the
action of the M2 ion channel (Pinto et al., 1992), is already
in clinical use. It has also been demonstrated that drugs,
such as cyclosporin A, that block the interaction of the
cellular chaperonin cyclophilin A with the viral capsid
protein, can selectively inhibit the appropriate disas-
sembly of HIV-1 virions and hence prevent HIV-1 infec-
tion in culture (Braaten et al., 1996). These precedents
suggest that a more complete understanding of how
other pathogenic viruses achieve the nuclear delivery
of their genetic information could lead to the develop-
ment of novel, and potentially highly effective, antiviral
drugs.
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